BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38386957)

  • 1. SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.
    Nagpal C; Sharma A; Bakhshi S; Malik PS; Gupta H; Mittal C; Gund S; Kumar A; Sharma A; Pushpam D; Khurana S; Pramanik R; Gupta N; Batra A
    JCO Glob Oncol; 2024 Feb; 10():e2300447. PubMed ID: 38386957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
    Kwon JH; Nam SH; Koh S; Hong YS; Lee KH; Shin SW; Hui D; Park KW; Yoon SY; Won JY; Chisholm G; Bruera E
    J Pain Symptom Manage; 2013 Dec; 46(6):947-56. PubMed ID: 23628516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
    Hannon B; Dyck M; Pope A; Swami N; Banerjee S; Mak E; Bryson J; Rodin G; Ridley J; Lo C; Le LW; Zimmermann C
    J Pain Symptom Manage; 2015 May; 49(5):945-52. PubMed ID: 25523890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.
    Merchant SJ; Kong W; Brundage M; Booth CM
    Ann Surg Oncol; 2021 Jan; 28(1):79-87. PubMed ID: 33140252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.
    Paiva CE; Manfredini LL; Paiva BS; Hui D; Bruera E
    PLoS One; 2015; 10(7):e0132073. PubMed ID: 26154288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
    Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
    McKenzie E; Zhang L; Chan S; Zaki P; Razvi Y; Tsao M; Barnes E; Drost L; Yee C; Hwang M; DeAngelis C; Chow E
    Support Care Cancer; 2020 Jan; 28(1):87-98. PubMed ID: 30982093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of a Symptom Assessment Tool in Shaping Patient-Physician Communication in Palliative Care.
    Brooks JV; Poague C; Formagini T; Sinclair CT; Nelson-Brantley HV
    J Pain Symptom Manage; 2020 Jan; 59(1):30-38. PubMed ID: 31494177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
    Tanco K; Vidal M; Arthur J; Delgado Guay M; Hui D; Liu D; Chisholm G; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):14-22. PubMed ID: 28264740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
    Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
    Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study.
    Batra A; Yang L; Boyne DJ; Harper A; Cuthbert CA; Cheung WY
    Support Care Cancer; 2021 Jun; 29(6):3299-3309. PubMed ID: 33104922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Validation of the Edmonton Symptom Assessment System in Chinese Patients.
    Dong Y; Chen H; Zheng Y; Guo Y; Kwon JH; Liu E; Guo H; Bruera E
    J Pain Symptom Manage; 2015 Nov; 50(5):712-17.e2. PubMed ID: 26386188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
    Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
    JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.